期刊文献+

α-干扰素在治疗Ph^-骨髓增殖性疾患中的应用

下载PDF
导出
摘要 IFN-α能抑制异常造血干细胞克隆和逆转骨髓纤维化,临床证实IFN-α在Ph^-骨髓增殖性疾患(MPD)患者中取得了一定疗效,为MPD患者提供了一种有效的治疗方法。
出处 《国外医学(输血及血液学分册)》 2001年第6期508-511,共4页 Foreign Medical Sciences(Section of Blood Transfusion and Heanatology)
  • 相关文献

参考文献5

  • 1E. Lengfelder,U. Berger,R. Hehlmann. Interferon α in the treatment of polycythemia vera[J] 2000,Annals of Hematology(3):103~109
  • 2T. Bachleitner-Hofmann,H. Gisslinger. The role of interferon-α in the treatment of idiopathic myelofibrosis[J] 1999,Annals of Hematology(12):533~538
  • 3M. Hino,E. Futami,S. Okuno,T. Miki,Y. Nishizawa,H. Morii. Possible selective effects of Interferon α-2b on a malignant clone in a case of polycythemia vera[J] 1993,Annals of Hematology(3):161~162
  • 4S. Sacchi,A. Tabilio,P. Leoni,A. Riccardi,A. Vecchi,C. Messora,F. Falzetti,S. Rupoli,G. Ucci,M. F. Martelli. Interferon alpha-2b in the long-term treatment of essential thrombocythemia[J] 1991,Annals of Hematology(4):206~209
  • 5M. J. B. P. Abegg-Werter,J. M. M. Raemaekers,B. E. Pauw,C. Haanen. Recombinant interferon-alpha, but not interferon-gamma is effective therapie for essential thrombocythemia[J] 1990,Blut(1):37~40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部